ADA’s Scientific Sessions: Day 2
Drs. Danny Chou, Peter Arvan, Jeffrey Millman, and Efsun Arda will share their key takeaways from day 2, with their…
ADA’s Scientific Sessions: Day 1
Here are Drs. Candace Reno and Luiza Caramori share their key takeaways from day 1, with their commentary in the…
Breakthrough T1D Heads, Virtually, to ADA’s 81st Scientific Sessions
At the ADA's 81st Scientific Sessions, healthcare professionals will gather at one of the largest conferences of diabetes researchers in…
Did You Know Our Website Is Accessible for People with Disabilities?
JDRF’s website uses accessiBe technology to improve accessibility and usability for people with physical and psychiatric disabilities.
You’re a Mathematician! No, I Just Have Type 1 Diabetes
It’s not an overstatement to say that, to effectively manage type 1 diabetes, one needs to be a mathematician. (Keep…
Mourning the Loss of a Breakthrough T1D Champion and Friend
There’s nothing bad you can say about John J. McDonough. He was a self-made man. He served on Breakthrough T1D’s…
COVID-19 and Type 1: School and Employment Rights, from a Lawyer
To help you traverse the school and employment rights with type 1 diabetes, Breakthrough T1D had a Facebook Live event…
Bench to Bedside: Breakthrough T1D-nPOD Conference
The 13th nPOD Annual Meeting was held February 22-24, 2021, and featured some of the most world-renowned diabetes investigators.
Breakthrough T1D Launches Third Center of Excellence in New England
The Breakthrough T1D New England Center of Excellence will focus on protecting the stem cell-derived beta cells from rejection by…
Timothy Doyle Joins Breakthrough T1D as President and Chief Operating Officer
Doyle will lead organizational operations to broaden Breakthrough T1D’s reach and impact.
